In2Pharma
  • Home
  • Services
    • Regulatory Affairs
    • Quality Assurance
    • Publicity and Compliance
    • Medical writing & training
    • Vigilance
  • About Us
  • News
  • Contact
Select Page
Diploma for the Responsible Person for Information and Publicity (RIP)

Diploma for the Responsible Person for Information and Publicity (RIP)

by In2Pharma | Mar 22, 2023 | News

Belgium The Royal Decree of April 7, 1995 on information and publicity of medicinal products for human use, describing which diplomas are eligible for recognition as RIP is being amended. The adaptation is made to follow the evolution in terminology of the relevant...

Recent Posts

  • Price display of OTC medicines
  • New fees for food supplement notifications
  • Revision IML Code of Ethics
  • New guideline on the use of D-mannose in food supplements
  • Adjusted fees for applications to EMA

Follow Us

  • Facebook
  • LinkedIn
Privacy Policy | Cookie Policy | BTW BE 895730662 | +32 16 89 16 00| info@in2pharma.com | Terloonststraat 22, 1910 Kampenhout, België